Furthermore, in the field of oncology research, the study by Malacrida et al. (2022) showed that HsEF has antitumor effects in both breast tumor cells examined and that the involvement of ERα (Estrogen Receptor alpha) could explain the differences observed between the two cell lines. Here, ESR1 is linked to breast neoplasm.